Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Jul 22 EFFECT Notice of effectiveness
- 1 Jul 22 POS AM Prospectus update (post-effective amendment)
- 5 Nov 21 424B5 Prospectus supplement for primary offering
- 7 May 21 424B5 Prospectus supplement for primary offering
- 12 Feb 21 424B5 Prospectus supplement for primary offering
- 14 Aug 20 EFFECT Notice of effectiveness
-
6 Aug 20 S-3 Shelf registration
SRRA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 3, 2020, relating to the financial statements of Sierra Oncology, Inc. appearing in the Annual Report on Form 10-K of Sierra Oncology, Inc. for the year ended December 31, 2019, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ DELOITTE & TOUCHE LLP |
Grand Rapids, Michigan |
August 6, 2020 |